ArticleNature communications2015

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes.

Feng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.